第一医药上半年净利1402.42万元，同比下降89.19%

Core Viewpoint - First Pharmaceutical (600833) reported a significant increase in revenue but a drastic decline in net profit for the first half of 2025, indicating potential challenges in profitability despite revenue growth [1] Financial Performance - The company achieved a revenue of 999.7 million yuan, representing a year-on-year growth of 11.58% [1] - The net profit attributable to shareholders was 14.02 million yuan, showing a year-on-year decrease of 89.19% [1] - Key financial metrics such as total profit, net profit attributable to shareholders, basic earnings per share, diluted earnings per share, and weighted average return on net assets all experienced a decline compared to the previous year [1] Explanation for Performance - The decline in profitability is primarily attributed to the previous year's compensation received from property expropriation, which significantly impacted the comparative financial results [1]